收藏切换
Study on the therapeutic effect of cinacalcet combined with renal failure mixture in chronic renal failure with secondary hyperparathyroidism
收藏切换
Yumeng SUN, Wei QU*, Wei LI
World Clinical Drug | 2025, 46(12) : 1270 - 1275
Less
收藏切换
World Clinical Drug | 2025, 46(12): 1270-1275
• Article •
Study on the therapeutic effect of cinacalcet combined with renal failure mixture in chronic renal failure with secondary hyperparathyroidism
Full
Yumeng SUN, Wei QU*, Wei LI
Affiliations
  • Department of Nephrology, Nantong Affiliated Hospital of Nanjing University of Chinese Medicine, Nantong 226001, Jiangsu Province, China
Published: 2025-12-10 doi: 10.13683/j.wph.2025.12.011
Outline
收藏切换
Objective

To explore the therapeutic effect of cinacalcet combined with renal failure mixture in chronic renal failure(CRF) with secondary hyperparathyroidism(SHPT) and its influence on fibroblast growth factor(FGF)-23,parathyroid hormone(PTH), and 25-hydroxyvitamin D3[25(OH)D3].

Methods

Patients with CRF accompanied by SHPT admitted to our hospital from January 2021 to December 2024 were selected for the study and randomly divided into the control group and the experimental group. All patients received hemodialysis treatment three times a week and were treated with calcium carbonate and renal failure mixture. The experimental group was given cinacalcet on the basis of the control group. The clinical efficacy, FGF-23, PTH, 25(OH)D3, blood calcium, blood phosphorus, calcium-phosphorus product, intact PTH(iPTH), thyroid volume and the occurrence of adverse reactions were compared between the two groups.

Result

After treatment, the total clinical effective rate of the experimental group was higher than that of the control group(84.91% vs. 67.31%), and the difference was significant(P<0.05). The levels of FGF-23, PTH, 25(OH) D3, blood calcium, blood phosphorus, calcium-phosphorus product, iPTH and thyroid volume in the peripheral blood of the experimental group were all lower than those of the control group(P<0.05). During the treatment period, there was no statistically significant difference in the occurrence of adverse reactions between the two groups(P>0.05).

Conclusion

Cinacalcet combined with renal failure mixture as an adjuvant therapy for CRF with SHPT has a better effect and can help reduce the levels of FGF-23, PTH and 25(OH)D3 in the peripheral blood of patients.

cinacalcet  /  renal failure mixture  /  chronic renal failure  /  hyperparathyroidism  /  fibroblast growth factor 23  /  parathyroid hormone  /  25-hydroxyvitamin D3
孙雨濛, 瞿伟, 李伟. 西那卡塞联合肾衰合剂对慢性肾衰竭伴继发性甲状旁腺功能亢进的疗效研究. 世界临床药物, 2025 , 46 (12) : 1270 -1275 . DOI: 10.13683/j.wph.2025.12.011
Yumeng SUN, Wei QU, Wei LI. Study on the therapeutic effect of cinacalcet combined with renal failure mixture in chronic renal failure with secondary hyperparathyroidism[J]. World Clinical Drug, 2025 , 46 (12) : 1270 -1275 . DOI: 10.13683/j.wph.2025.12.011
Year 2025 volume 46 Issue 12
47
14
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.12.011
  • Receive Date:2025-07-23
  • Online Date:2026-11-09
  • Published:2025-12-10
Article Data
Affiliations
History
  • Received:2025-07-23
Funding
Affiliations
    Department of Nephrology, Nantong Affiliated Hospital of Nanjing University of Chinese Medicine, Nantong 226001, Jiangsu Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.12.011
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT